ReviewBiomedicines2026

Repurposing Tyrosine Kinase Inhibitors for Sickle Cell Disease: Focus on Band 3 Phosphorylation.

Raj Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.